Cargando…
Adjuvant therapies for resected limited-stage small cell lung cancer
Autor principal: | Lampridis, Savvas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390139/ https://www.ncbi.nlm.nih.gov/pubmed/36004158 http://dx.doi.org/10.1016/j.xjon.2021.05.018 |
Ejemplares similares
-
Mediastinal radiotherapy after adjuvant chemotherapy for resected non–small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis
por: Harling, Leanne, et al.
Publicado: (2020) -
A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)
por: Kunitoh, Hideo, et al.
Publicado: (2020) -
Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy
por: Tang, Andrew, et al.
Publicado: (2022) -
Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023) -
Nonintubated versus intubated “one-stage” preoperative localization and thoracoscopic lung resection
por: Hsu, Po-Kuei, et al.
Publicado: (2021)